US price-fixing litigation targeting Teva has been selected as a priority for trial, making it a “bellwether” case, as part of the wider ongoing US investigation into generic price-fixing allegations.
The decision by a district court for the eastern district of Pennsylvania came shortly after a third major price-fixing lawsuit...






